Relation of a TNF gene polymorphism to severe sepsis in trauma patients

Annals of Surgery

Volumn 230, Issue 2, 1999, Pages 207-214

  Majetschak, Matthias ^a   Flohé, Sascha ^a   Obertacke, Udo ^a   Schröder, Jörg ^c   Staubach, Karl ^d   Nast Kolb, Dieter ^a   Schade, F Ulrich ^a   Stüber, Frank ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; LYMPHOTOXIN;

ADULT; AGED; ALLELE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; INJURY; INTRON; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEPSIS;

ADULT; ALLELES; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEPSIS; TRAUMA SEVERITY INDICES; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS, NONPENETRATING;

EID: 0033498342     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199908000-00011     Document Type: Article

References (47)

1. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658.
2. Parillo JE, Parker MM, Natanson C, et al. Septic shock: Advances in the understanding of the pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242.
3. Niedermann MS, Fein AM. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: A common clinical sequence. Clin Chest Med 1990; 11:633-650.
4. American College of Chest Physicians - Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-875.
5. Bone CR. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med 1996; 125:680-687.
6. Centers of Disease Control and Prevention. National Center for Health and Statistics. Mortality patterns - United States, 1990. Monthly Vital Stat Rep 1993; 41:5.
7. Freeman BD, Natanson C. Clinical trials in sepsis and septic shock in 1994 and 1995. Current Opinion in Critical Care 1995; 1:349-357.
8. Beutler B, Grau GE. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit Care Med 1993; 21:5423-435.
9. Stricter RN, Kunkel SL, Bone RC. Role of tumor necrosis factor alpha in disease states and inflammation. Crit Care Med 1993; 21:5447-463.
10. DiPiro JT, Howdieshell TR, Goddard JK, et al. Association of interleukin-4 plasma levels with traumatic injury and clinical course. Arch Surg 1995; 130:1159-1163.
11. Roumen RMH, Hendriks T, van der Ven-Jongenkrijk J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Ann Surg 1993; 218:769-776.
12. Ertel W, Keel M, Bonaccio M, et al. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 1995; 39:879-887.
13. Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 1996; 24:392-397.
14. Stüber F, Petersen M, Bokelmann F, Schade U. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-a concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24:381-384.
15. Pociot F, Molvig J, Wogensen L, et al. A tumor necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Scand J Immunol 1991; 33:37-49.
16. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex with the secretion of TNF-alpha and TNF-beta by human mononuclear cells; A possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:224-231.
17. Fugger L, Morling N, Ryder P, et al. Ncol restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFa) region in four autoimmune diseases. Tissue Antigens 1989; 34:17-22.
18. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: An Nco 1 polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med 1991; 173:209-219.
19. Molvig J, Pociot F, Baek L, et al. Monocyte function in IDDM patients and healthy individuals. Scand J Immunol 1990; 31:297-306.
20. Greenspan L, McLellan BA, Greig H. Abbreviated injury scale and injury severity score: A scoring chart. J Trauma 1985; 25:60-64.
21. Goris RJ, te-Boekhorst TP, Nuytinck JK, et al. Multiple-organ failure; Generalized autodestructive inflammation? Arch Surg 1985; 120; 1109-1115.
22. Mock CN, Jurkovich GF, Dries D, Maier RV. The clinical significance of endotoxin released by antibiotics: What is the evidence? J Endotox Res 1996; 3:253-259.
23. Majetschak M, Flach R, Heukamp T, et al. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma. J Trauma 1997; 43:880-887.
24. Majetschak M, Flach R, Jennissen V, et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 1999; 27:313-318.
25. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A laboratory manual, 2d ed. New York: Cold Spring Harbor Laboratory Press; 1989:14-21.
26. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748.
27. Broos PL, D'Hoore A, Vanderschot P, et al. Multiple trauma in elderly patients. Factors influencing outcome: Importance of aggressive care. Injury 1993; 24:365-368.
28. Aufmkolk M, Majetschak M, Voggenreiter G, et al. Outcome and prognosis after multiple trauma in the aged. Unfallchirurg 1997; 100; 477-482.
29. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469.
30. Beutler B, Cerami A. Cachectin: More than a tumor necrosis factor. N Engl J Med 1987; 316:379-385.
31. Westendorp RGJ. Langermans JAM, Huizinga TWJ, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349:170-173.
32. Sorensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med 1988; 318:727-732.
33. Pauli U. Control of tumor necrosis factor gene expression. Crit Rev Eukar Gen Expr 1994; 4:323-344.
34. Trowsdale J. Genomic structure and function in the MHC. Trends Genet 1993; 9:117-122.
35. McGuire W, Hill AVS, Allsopp CEM, et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-511.
36. Cabrera M, Shaw MA, Sharples C, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182:1259-1264.
37. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor α promoter polymorphism effects transcription. Mol Immun 1997; 34:391-399.
38. Stüber F, Udalova IA, Book M, et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflam 1996; 46:42-50.
39. Fugger L, Morling N, Ryder LP, et al. Ncol restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNFα) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989; 30:185-189.
40. Laitinen T, Lokki ML, Tulppala M, et al. Tumor necrosis β gene polymorphism in relation to complotype in couples with spontaneous abortions and in control families. Scand J Immunol 1992; 35:131-135.
41. Peruccio D. D'Alfonso S. Borelli I, etal. Distribution of tumor necrosis factor alleles (Nco 1 RFLP) and their relationship to HLA haplotypes in an Italian population. Hum Hered 1993; 43: 103-110.
42. Camphell DA, Nelson S, Madhok R, et al. TNF Nco-I RFLP is not an independent risk factor in rheumatoid arthritis. Eur J Immunogen 1994; 21:461-467.
43. Park KS, Mok JW, Kim MY. Analysis of the first intron of TNFβ gene by Nco 1 RFLP in Koreans. Jpn J Hum Genet 1997; 42:357-362.
44. Mock CN, Jurkovich GJ, Dries DJ, Maier RV, Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 1995; 130:1234-1241.
45. Cinnat M, Waxman K, Granger GA, et al. Trauma causes sustained elevation of soluble tumor necrosis factor receptors. J Am Coll Surg 1994; 179:529-537.
46. Svodoba P, Kantorova I, Ochmann J. Dynamics of interleukin 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 1994; 36:336-340.
47. Donelly TJ, Meade P, Jagels M, et al. Cytokine, complement, and endotoxin profiles associated with the development of the adult respiratory distress syndrome after severe injury. Crit Care Med 1994; 22:768-776.